No Image Available

Sodium Bicarbonate film coated Generics

Form: Tablet, sachet and oral suspension

Strength: 1,000 mg/5 mL , 1,200 mg/5 mL, 1,000 mg per sachet , 1,200 mg per sachet

Reference Brands: Neut®, Alka-Seltzer® (effervescent), Effer-K®(US), Sodrox®(EU)

Category: Nephrology

Sodium Bicarbonate Film-Coated Tablets are essential in the management of metabolic acidosis, especially in patients with chronic kidney disease (CKD). These tablets act as systemic alkalinizers, helping maintain acid-base balance by increasing serum bicarbonate levels. The film coating enhances palatability and gastrointestinal tolerance, improving patient adherence. Widely used in nephrology, this formulation supports renal function by reducing acid load and preventing complications related to acidosis. Ideal for B2B pharmaceutical distributors in the US and EU, Sodium Bicarbonate Tablets are available in multiple strengths and packaging formats suitable for both hospital and retail markets.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Calcitriol Generics

Strength: Capsules:0.25 mcg, 0.5 mcg; Injection:1 mcg/mL

Form: Capsules & Injection

Reference Brands: Rocaltrol®(EU & US), Calcijex® (US)

View Details Get Enquiry
Paricalcitol Generics

Strength: Capsules:1mcg, 2mcg, 4 mcg & Injection: 2mcg/mL , 5mcg/mL

Form: Capsules and Injection

Reference Brands: Zemplar®(US &EU)

View Details Get Enquiry
Calcifediol(Ref.Brand: Rayaldee®(US) Generics

Strength: 30 mcg

Form: ER Oral Capsule

Reference Brands:

View Details Get Enquiry
Methoxy Polyethylene Glycol-Epoetin Beta Generics

Strength: 25–250 mcg

Form: Solution for Injection

Reference Brands: Mircera® (US &EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

We use cookies to ensure you get the best experience on our website. Learn more